Cargando…

An Isoform of Nedd4-2 Plays a Pivotal Role in Electrophysiological Cardiac Abnormalities

We have previously shown that neural precursor cell-expressed developmentally downregulated gene 4-2 (Nedd4-2) isoforms with a C2 domain are closely related to ubiquitination of epithelial sodium channel (ENaC), resulting in salt-sensitive hypertension by Nedd4-2 C2 targeting in mice. The sodium vol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Minegishi, Shintaro, Ishigami, Tomoaki, Kawamura, Hisho, Kino, Tabito, Chen, Lin, Nakashima-Sasaki, Rie, Doi, Hiroshi, Azushima, Kengo, Wakui, Hiromichi, Chiba, Yumi, Tamura, Kouichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486090/ https://www.ncbi.nlm.nih.gov/pubmed/28613240 http://dx.doi.org/10.3390/ijms18061268

Ejemplares similares

Eplerenone-Resistant Salt-Sensitive Hypertension in Nedd4-2 C2 KO Mice
por: Kino, Tabito, et al.
Publicado: (2017)

Blood Pressure Elevation of Tubular Specific (P)RR Transgenic Mice and Lethal Tubular Degeneration due to Possible Intracellular Interactions between (P)RR and Alternative Renin Products
por: Saigo, Sae, et al.
Publicado: (2021)

An isoform of Nedd4-2 is critically involved in the renal adaptation to high salt intake in mice
por: Minegishi, Shintaro, et al.
Publicado: (2016)

Regulators of Epithelial Sodium Channels in Aldosterone-Sensitive Distal Nephrons (ASDN): Critical Roles of Nedd4L/Nedd4-2 and Salt-Sensitive Hypertension
por: Ishigami, Tomoaki, et al.
Publicado: (2020)

Commensal Microbe-specific Activation of B2 Cell Subsets Contributes to Atherosclerosis Development Independently of Lipid Metabolism
por: Chen, Lin, et al.
Publicado: (2016)

Native T1 time and extracellular volume fraction in differentiation of normal myocardium from non-ischemic dilated and hypertrophic cardiomyopathy myocardium: A systematic review and meta-analysis
por: Minegishi, Shintaro, et al.
Publicado: (2019)

Lubiprostone as a potential therapeutic agent to improve intestinal permeability and prevent the development of atherosclerosis in apolipoprotein E-deficient mice
por: Arakawa, Kentaro, et al.
Publicado: (2019)

Impact of the COVID-19 pandemic on physical and psychological activities in elderly patients with hypertension
por: Azushima, Kengo, et al.
Publicado: (2022)

Effects of rikkunshito on renal fibrosis and inflammation in angiotensin II-infused mice
por: Azushima, Kengo, et al.
Publicado: (2019)

Enhancement of intrarenal plasma membrane calcium pump isoform 1 expression in chronic angiotensin II‐infused mice
por: Wakui, Hiromichi, et al.
Publicado: (2017)

Updates for Cardio‐Kidney Protective Effects by Angiotensin Receptor‐Neprilysin Inhibitor: Requirement for Additional Evidence of Kidney Protection
por: Tsukamoto, Shunichiro, et al.
Publicado: (2023)

Early Enhanced Leucine-Rich α-2-Glycoprotein-1 Expression in Glomerular Endothelial Cells of Type 2 Diabetic Nephropathy Model Mice
por: haku, Sona, et al.
Publicado: (2018)

Effects of ATRAP in Renal Proximal Tubules on Angiotensin‐Dependent Hypertension
por: Kinguchi, Sho, et al.
Publicado: (2019)

ATRAP Expression in Brown Adipose Tissue Does Not Influence the Development of Diet-Induced Metabolic Disorders in Mice
por: Ohki, Kohji, et al.
Publicado: (2017)

Angiotensin II Type 1 Receptor‐Associated Protein Regulates Kidney Aging and Lifespan Independent of Angiotensin
por: Uneda, Kazushi, et al.
Publicado: (2017)

Angiotensin II Type 1 Receptor-associated Protein Inhibits Angiotensin II-induced Insulin Resistance with Suppression of Oxidative Stress in Skeletal Muscle Tissue
por: Ohki, Kohji, et al.
Publicado: (2018)

Effects of Rikkunshito treatment on renal fibrosis/inflammation and body weight reduction in a unilateral ureteral obstruction model in mice
por: Wakui, Hiromichi, et al.
Publicado: (2020)

Rationale and Design of the Orencia Atherosclerosis and Rheumatoid Arthritis Study (ORACLE Arthritis Study): Implications of Biologics against Rheumatoid Arthritis and the Vascular Complications, Subclinical Atherosclerosis
por: Ishigami, Tomoaki, et al.
Publicado: (2021)

Systematic review and meta-analysis for prevention of cardiovascular complications using GLP-1 receptor agonists and SGLT-2 inhibitors in obese diabetic patients
por: Uneda, Kazushi, et al.
Publicado: (2021)

Comparative Efficacy of Pharmacological Treatments for Adults With Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
por: Tsukamoto, Shunichiro, et al.
Publicado: (2022)

Effects of a High-Protein Diet on Kidney Injury under Conditions of Non-CKD or CKD in Mice
por: Tanaka, Shohei, et al.
Publicado: (2023)

Effects of Single Pill-Based Combination Therapy of Amlodipine and Atorvastatin on Within-Visit Blood Pressure Variability and Parameters of Renal and Vascular Function in Hypertensive Patients with Chronic Kidney Disease
por: Azushima, Kengo, et al.
Publicado: (2014)

Comparison of the effects of weekly and biweekly intravenous CERA administration on erythropoiesis: A randomized controlled trial
por: Kawai, Yuki, et al.
Publicado: (2021)

Bofu-Tsu-Shosan, an Oriental Herbal Medicine, Exerts a Combinatorial Favorable Metabolic Modulation Including Antihypertensive Effect on a Mouse Model of Human Metabolic Disorders with Visceral Obesity
por: Azushima, Kengo, et al.
Publicado: (2013)

Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia
por: Ohsawa, Masato, et al.
Publicado: (2015)

Effects of tumor necrosis factor-α inhibition on kidney fibrosis and inflammation in a mouse model of aristolochic acid nephropathy
por: Taguchi, Shinya, et al.
Publicado: (2021)

Metabolic dysfunction-associated fatty liver disease reflects a significantly higher risk of hypertension than non-alcoholic fatty liver disease
por: Uehara, Tatsuki, et al.
Publicado: (2023)

Gut microbiota and atherosclerosis: role of B cell for atherosclerosis focusing on the gut-immune-B2 cell axis
por: Chen, Lin, et al.
Publicado: (2020)

The Types and Proportions of Commensal Microbiota Have a Predictive Value in Coronary Heart Disease
por: Chen, Lin, et al.
Publicado: (2021)

Addition of Aliskiren to Angiotensin Receptor Blocker Improves Ambulatory Blood Pressure Profile and Cardiorenal Function Better than Addition of Benazepril in Chronic Kidney Disease
por: Ohsawa, Masato, et al.
Publicado: (2013)

L/N-Type Calcium Channel Blocker Cilnidipine Added to Renin-Angiotensin Inhibition Improves Ambulatory Blood Pressure Profile and Suppresses Cardiac Hypertrophy in Hypertension with Chronic Kidney Disease
por: Kanaoka, Tomohiko, et al.
Publicado: (2013)

Optimal Anticoagulant Strategy for Periprocedural Management of Atrial Fibrillation Ablation: A Systematic Review and Network Meta-Analysis
por: Kino, Tabito, et al.
Publicado: (2022)

Adipocyte‐Specific Enhancement of Angiotensin II Type 1 Receptor‐Associated Protein Ameliorates Diet‐Induced Visceral Obesity and Insulin Resistance
por: Azushima, Kengo, et al.
Publicado: (2017)

Author Correction: Angiotensin II type-1 receptor-associated protein interacts with transferrin receptor-1 and promotes its internalization
por: Abe, Eriko, et al.
Publicado: (2022)

Angiotensin II type-1 receptor-associated protein interacts with transferrin receptor-1 and promotes its internalization
por: Abe, Eriko, et al.
Publicado: (2022)

Angiotensin II type 1 receptor-associated protein deficiency attenuates sirtuin1 expression in an immortalised human renal proximal tubule cell line
por: Yamaji, Takahiro, et al.
Publicado: (2019)

Aristolochic Acid Induces Renal Fibrosis and Senescence in Mice
por: Urate, Shingo, et al.
Publicado: (2021)

Effects of the Angiotensin Receptor Blocker Olmesartan on Adipocyte Hypertrophy and Function in Mice with Metabolic Disorders
por: Maeda, Akinobu, et al.
Publicado: (2014)

Upstream Stimulatory Factors 1 and 2 Mediate the Transcription of Angiotensin II Binding and Inhibitory Protein
por: Matsuda, Miyuki, et al.
Publicado: (2013)

Effects of Ang II Receptor Blocker Irbesartan on Adipose Tissue Function in Mice with Metabolic Disorders
por: Maeda, Akinobu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ut1drgmdskuo79185r3m2m0rji